Net debt/EBITDA spoločnosti Acceleron Pharma Inc
Aká je hodnota metriky Net debt/EBITDA spoločnosti Acceleron Pharma Inc?
Hodnota metriky Net debt/EBITDA spoločnosti Acceleron Pharma Inc je 10.60
Aká je definícia metriky Net debt/EBITDA?
The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.
The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.
Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization
Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.
Net debt/EBITDA spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou Acceleron Pharma Inc
Čomu sa venuje spoločnosť Acceleron Pharma Inc?
Acceleron is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Acceleron's leadership in the understanding of TGF-beta superfamily biology and protein engineering generates innovative compounds that engage the body's ability to regulate cellular growth and repair.
Firmy s metrikou net debt/ebitda podobnou spoločnosti Acceleron Pharma Inc
- Hodnota metriky Net debt/EBITDA spoločnosti GGL Resources je 10.59
- Hodnota metriky Net debt/EBITDA spoločnosti T-Mobile US je 10.59
- Hodnota metriky Net debt/EBITDA spoločnosti WorleyParsons je 10.59
- Hodnota metriky Net debt/EBITDA spoločnosti WorleyParsons je 10.59
- Hodnota metriky Net debt/EBITDA spoločnosti Colfax Corp je 10.59
- Hodnota metriky Net debt/EBITDA spoločnosti The Cooper Companies je 10.59
- Hodnota metriky Net debt/EBITDA spoločnosti Acceleron Pharma Inc je 10.60
- Hodnota metriky Net debt/EBITDA spoločnosti Faurecia S.E je 10.60
- Hodnota metriky Net debt/EBITDA spoločnosti Kellogg je 10.61
- Hodnota metriky Net debt/EBITDA spoločnosti Saputo je 10.61
- Hodnota metriky Net debt/EBITDA spoločnosti Aon plc je 10.62
- Hodnota metriky Net debt/EBITDA spoločnosti Olema Pharmaceuticals je 10.62
- Hodnota metriky Net debt/EBITDA spoločnosti RealPage je 10.63